breast cancer - HER2-positive | ||
es-BC - HER2 positive - (neo)adjuvant (NA) | la/mBC - HER2 positive - 1st Line (L1) | |
pertuzumab plus trastuzumab | IMpassion-050 IMpassion-050 IMpassion-050 | PERTAIN |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -